sftd
New Bristol-Meyers Squibb's New Anti-Cancer Treatment: Ixempra, FDA-Approved
Filed in archive Cancer , FDA Approvals , Treatment by Gloria Gamat on October 22, 2007
A new anti-cancer treatment distributed by Bristol-Meyers Squibb Company (Princeton, New Jersey) -Ixempra (ixabepilone) - has recently been approved by the US FDA for use use in patients with metastatic or locally advanced breast cancer who have not responded to certain other cancer drugs.

19090791.jpg


The approval of Ixempra includes the following:

  • for use in combination with another cancer drug (capecitabine) in patients who no longer benefit from two other chemotherapy treatments: including an anthracycline (such as doxorubicin or epirubicin) and a taxane (such as paclitaxel or docetaxel)

  • for use alone in patients who no longer benefit from an anthracycline, a taxane and capecitabine



Administered by intravenous infusion, Ixempra has been shown to bind to cancer cell microtubules but with some side effects: peripheral neuropathy (numbness, tingling or burning in the hands or feet), bone marrow suppression, constipation, nausea, vomiting, muscle paint, joint pain, fatigue and general weakness.

Well, which anti-cancer treatment does not have side effects?

Anyways, find more details about the FDA approval of Ixempra from the FDA News and BMS' press release.



Permalink: New Bristol-Meyers Squibb's New Anti-Cancer Treatment: Ixempra, FDA-Approved
Tags: anticancer  treatment  breast  cancer  metastatic  breast  cancer  Ixempra  health  cancer+treatment 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/98291
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for New Bristol-Meyers Squibb's New Anti-Cancer Treatment: Ixempra, FDA-Approved:

  • Currently 6.33/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.33 out of 3 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!